1.中国中医科学院西苑医院国家中医心血管病临床医学研究中心 北京 100091
2.中国中医科学院广安门医院博士后流动站
3.福建中医药大学中西医结合学院
4.中国医学科学院阜外医院冠心病中心
李洪峥,女,博士,住院医师
#于子凯,男,博士,副研究员,主治医师,主要研究方向:中西医结合防治心血管病,E-mail:ztyuzikai@163.com
收稿:2024-05-08,
纸质出版:2024-11-30
移动端阅览
李洪峥, 刘天娇, 商祖诚, 等. 三七总皂苷抑制JNK/c-Jun信号通路干预钙化性主动脉瓣疾病的效应及机制研究[J]. 北京中医药大学学报, 2024,47(11):1550-1561.
LI Hongzheng, LIU Tianjiao, SHANG Zucheng, et al. The effect and mechanism of
李洪峥, 刘天娇, 商祖诚, 等. 三七总皂苷抑制JNK/c-Jun信号通路干预钙化性主动脉瓣疾病的效应及机制研究[J]. 北京中医药大学学报, 2024,47(11):1550-1561. DOI: 10.3969/j.issn.1006-2157.2024.11.010.
LI Hongzheng, LIU Tianjiao, SHANG Zucheng, et al. The effect and mechanism of
目的
2
探讨三七总皂苷调控c-Jun氨基端激酶(JNK)/c-Jun信号通路改善小鼠钙化性主动脉瓣疾病的作用与机制。
方法
2
将21只6~8周龄雄性ApoE
-/-
小鼠,按随机数字表法分
为模型组、三七总皂苷高剂量组(60 mg/kg)、三七总皂苷低剂量组(30 mg/kg),每组7只;另设9只6~8周龄雄性C57BL/6小鼠为对照组。予对照组小鼠普通饲料饲养,予ApoE
-/-
小鼠高脂饲料饲养12周。12周后,随机选取ApoE
-/-
小鼠每组各1只和C57BL/6小鼠3只,评估造模效果。确认造模成功后,予三七总皂苷高、低剂量组小鼠每日灌胃相应药物,对照组、模型组小鼠灌胃等体积生理盐水,连续4周。治疗结束后,超声检测各组小鼠瓣环直径、峰值流速;硝酸银(von Kossa)染色、茜素红S染色评估主动脉瓣钙化程度;生化法检测甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)水平;酶联免疫吸附试验检测血清白细胞介素-4(IL-4) 、肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)、白细胞介素-10(IL-10)含量;免疫组织化学法检测钙化标志物Runt相关转录因子2(RUNX2)、骨形态发生蛋白2(BMP2)阳性染色率;TUNEL染色评估主动脉瓣细胞凋亡情况;实时荧光PCR、免疫荧光检测JNK/c-Jun信号通路相关指标mRNA表达和平均荧光强度。
结果
2
与对照组比较,模型组小鼠血清TC、TG、LDL-C、TNF-α、IL-1β升高,IL-4、IL-10降低,瓣环直径减小,峰值流速升高,von Kossa、茜素红S染色阳性面积占比增多,主动脉瓣细胞凋亡率升高,BMP2、RUNX2阳性染色率增加,JNK与c-Jun mRNA表达水平、p-JNK/JNK、p-c-Jun/c-Jun均升高(均
P
<
0.05)。与模型组比较,三七总皂苷低剂量组小鼠血清TC、LDL-C、TNF-α降低,瓣环直径增大,峰值流速降低,茜素红S染色阳性面积减少,BMP2、RUNX2阳性染色率、JNK和c-Jun mRNA表达水平、p-JNK/JNK、p-c-Jun/c-Jun均降低(均
P
<
0.05);三七总皂苷高剂量组血清HDL-C、IL-4、IL-10升高,TC、LDL-C、TNF-α、IL-1β降低,瓣环直径增大,峰值流速降低,von Kossa与茜素红S染色阳性面积占比减少、细胞凋亡染色率降低,BMP2与RUNX2阳性染色率降低,JNK、c-Jun mRNA表达水平及p-JNK/JNK、p-c-Jun/c-Jun均降低(均
P
<
0.05)。
结论
2
三七总皂苷可通过抑制JNK/c-Jun信号通路,减少瓣膜细胞凋亡,降低炎症水平,减轻小鼠主动脉瓣钙化程度。
Objective
2
To investigate the effect and mechanism of
Panax notoginseng
saponins (PNS) in inhibiting c-Jun N-terminal protein kinase (JNK)/c-Jun signaling pathway activation to alleviate calcific aortic valve disease (CAVD) in mice.
Methods
2
Twenty-one male ApoE
-/-
mice aged 6 to 8 weeks were randomly divided into the model
PNS high-dose (60 mg/kg)
and PNS low-dose (30 mg/kg) groups using the random number table method
with seven mice per group. Nine male C57BL/6 mice aged 6 to 8 weeks were used as the control group. Mice in the control group were fed a normal diet
whereas ApoE
-/-
mice were fed a high-fat diet for 12 weeks. After 12 weeks
three C57BL/6 and
three ApoE
-/-
mice (one ApoE
-/-
mice from each group) were randomly selected to evaluate the CAVD modeling effect. After confirming successful modeling
the PNS high- and low-dose groups received daily intragastric PNS administration. The control and model groups were administered an equal volume of stroke-physiological saline solution by gavage for 4 consecutive weeks. The valve annulus diameter and peak velocity of the mice in each group were then detected using ultrasound. The degree of aortic valve calcification was evaluated using von Kossa and Alizarin Red S staining. The serum triglycerides (TG)
total cholesterol (TC)
low-density lipoprotein cholesterol (LDL-C)
and high-density lipoprotein cholesterol (HDL-C) were detected by biochemical method. Inflammatory factor interleukin-4 (IL-4)
tumor necrosis factor-α (TNF-α)
interleukin-1β (IL-1β)
and interleukin-10 (IL-10) levels were determined using an enzyme-linked immunosorbent assay. The expressions of calcification markers
runt-related transcription factor 2 (RUNX2)
and bone morphogenetic protein 2 (BMP2) were detected using immunohistochemistry. Aortic valve cell apoptosis was evaluated using TUNEL staining
and JNK/c-Jun signaling pathway-related mRNA and mean fluorescence intensity were detected using quantitative real-time PCR and immunofluorescence
respectively.
Results
2
Compared with the control group
the mice in the model group showed an increase in serum TC
TG
LDL-C
TNF-α
and IL-1β levels
a decrease in IL-4 and IL-10 levels
a decrease in annulus diameter
an increase in peak flow velocity
and an increase in von Kossa and Alizarin Red S staining-positive areas. Additionally
the model group showed an increase in aortic valve cell apoptosis rate
an increase in BMP2 and RUNX2-positive rates
and an increase in JNK and c-Jun mRNA expression levels and p-JNK/JNK and p-c-Jun/c-Jun (
P
<
0.05). Compared to the model group
the PNS low-dose group showed a decrease in seru
m TC
LDL-C
and TNF-α levels
an increase in annulus diameter
a decrease in peak flow velocity
and a decrease in positive area in Alizarin Red S staining. Furthermore
the PNS low-dose group showed a decrease in BMP2 and RUNX2-positive rates
JNK and c-Jun mRNA expression levels
and p-JNK/JNK and p-c-Jun/c-Jun (
P
<
0.05). The PNS high-dose group showed an increase in HDL-C
IL-4 and IL-10 levels
a decrease in serum TC
LDL-C
TNF-α
and IL-1β levels
an increase in annulus diameter
a decrease in peak flow velocity
and a decrease in von Kossa and Alizarin Red S staining-positive areas and cell apoptosis rate. The PNS high-dose group also showed a decrease in BMP2 and RUNX2 positive staining rates
JNK and c-Jun mRNA expression levels
and p-JNK/JNK and p-c-Jun/c-Jun (
P
<
0.05).
Conclusion
2
PNS may reduce valvular cell apoptosis
alleviate inflammation
and protect against aortic valve calcification in mice by inhibiting the activation of JNK/c-Jun signaling pathway.
SMALL AM , YUTZEY KE , BINSTADT BA , et al . Unraveling the mechanisms of valvular heart disease to identify medical therapy targets: a scientific statement from the American heart association [J ] . Circulation , 2024 , 150 ( 6 ): e109 - e128 .
MOURA LM , RAMOS SF , ZAMORANO JL , et al . Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis [J ] . J Am Coll Cardiol , 2007 , 49 ( 5 ): 554 - 561 .
Cowell SJ , Newby DE , Prescott RJ , et al . A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis [J ] . N Engl J Med , 2005 , 352 ( 23 ): 2389 - 2397 .
国家中医心血管病临床医学研究中心 , 中国医师协会中西医结合医师分会 , 中国中西医结合学会活血化瘀专业委员会 , 等 . 三七总皂苷制剂临床应用中国专家共识 [J ] . 中国中西医结合杂志 , 2021 , 41 ( 10 ): 1157 - 1167 .
魏玥 , 付长庚 , 李洪峥 , 等 . 三七总皂苷对动脉粥样硬化小鼠M1型、M2型巨噬细胞极化的影响 [J ] . 环球中医药 , 2023 , 16 ( 11 ): 2171 - 2178 .
GARG V . The role of lipoprotein(a) in calcific aortic valve disease: insights from a large-cohort genetic study [J ] . JAMA Cardiol , 2018 , 3 ( 1 ): 24 - 25 .
ZHU ZJ , LIU ZR , ZHANG DH , et al . Models for calcific aortic valve disease in vivo and in vitro [J ] . Cell Regen , 2024 , 13 ( 1 ): 6 .
ZHOU YZ , YUAN ZS , WANG M , et al . Liraglutide attenuates aortic valve calcification in a high-cholesterol-diet-induced experimental calcific aortic valve disease model in apolipoprotein E-deficient mice [J ] . J Cardiovasc Dev Dis , 2023 , 10 ( 9 ): 386 .
VOGL BJ , NIEMI NR , GRIFFITHS LG , et al . Impact of calcific aortic valve disease on valve mechanics [J ] . Biomech Model Mechanobiol , 2022 , 21 ( 1 ): 55 - 77 .
胡盛寿 , 王增武 . 《中国心血管健康与疾病报告2022》概述 [J ] . 中国心血管病研究 , 2023 , 21 ( 7 ): 577 - 600 .
YANG Y , WANG ZW , CHEN Z , et al . Current status and etiology of valvular heart disease in China: a population-based survey [J ] . BMC Cardiovasc Disord , 2021 , 21 ( 1 ): 339 .
YU JY , WANG Z , BAO QY , et al . Global burden of calcific aortic valve disease and attributable risk factors from 1990 to 2019 [J ] . Front Cardiovasc Med , 2022 , 9 : 1003233 .
MOHAMMADYARI P , VIECELI DALLA SEGA F , FORTINI F , et al . Deep-learning survival analysis for patients with calcific aortic valve disease undergoing valve replacement [J ] . Sci Rep , 2024 , 14 ( 1 ): 10902 .
MONCLA LM , BRIEND M , BOSSÉ Y , et al . Calcific aortic valve disease: mechanisms, prevention and treatment [J ] . Nat Rev Cardiol , 2023 , 20 ( 8 ): 546 - 559 .
YANG XC , XIONG XJ , WANG J . Sanqi Panax notoginseng injection for angina pectoris [J ] . Evid Based Complement Alternat Med , 2014 , 2014 : 963208 .
DUAN L , XIONG XJ , HU JY , et al . Panax notoginseng saponins for treating coronary artery disease: a functional and mechanistic overview [J ] . Front Pharmacol , 2017 , 8 : 702 .
乔园 , 段惠惠 , 黄建梅 , 等 . 三七总皂苷对高糖诱导大鼠视网膜微血管内皮细胞损伤的保护作用 [J ] . 北京中医药大学学报 , 2015 , 38 ( 5 ): 318 - 322, 361 .
李巾伟 , 朱培纯 , 司银楚 , 等 . 三七总皂甙对脑出血大鼠前脑促凋亡基因caspase-3影响的研究 [J ] . 北京中医药大学学报 , 2003 , 26 ( 2 ): 22 - 25 .
朱军凤 , 姜旭 , 陈溢滢 , 等 . 三七总皂苷对ApoE -/- 小鼠动脉粥样硬化斑块形成及自噬的影响 [J ] . 河南中医 , 2023 , 43 ( 3 ): 378 - 384 .
张梦 , 萧闵 , 蔡婷 , 等 . 三七皂苷R 1 调控Nrf2介导的铁死亡途径改善ApoE -/- 小鼠动脉粥样硬化 [J ] . 中草药 , 2024 , 55 ( 15 ): 5135 - 5144 .
林松春 , 陈瑞芹 , 刘福招 . 三七双降汤联合常规西药治疗高血压伴动脉粥样硬化对血压血脂的影响 [J ] . 实用中西医结合临床 , 2022 , 22 ( 8 ): 17 - 20 .
XU Y , TAN HY , LI S , et al . Panax notoginseng for inflammation-related chronic diseases: a review on the modulations of multiple pathways [J ] . Am J Chin Med , 2018 , 46 ( 5 ): 971 - 996 .
YANG H , LIU ZD , HU XK , et al . Protective effect of Panax notoginseng saponins on apolipoprotein-E-deficient atherosclerosis-prone mice [J ] . Curr Pharm Des , 2022 , 28 ( 8 ): 671 - 677 .
江小萍 , 曾凡鹏 , 刘首明 , 等 . 血塞通软胶囊治疗高脂血症动脉粥样硬化36例临床观察 [J ] . 湖南中医杂志 , 2021 , 37 ( 3 ): 11 - 13 .
赵培 , 李永辉 , 高伟 , 等 . 三七总皂苷通过调节TLR4/SYK信号抑制ApoE基因敲除小鼠动脉粥样硬化泡沫细胞的形成 [J ] . 天然产物研究与开发 , 2021 , 33 ( 8 ): 1267 - 1273 .
LI GZ , SHEN N , DENG HF , et al . Abnormal mechanical stress on bicuspid aortic valve induces valvular calcification and inhibits Notch1/NICD/Runx2 signal [J ] . PeerJ , 2023 , 11 : e14950 .
KHAN K , YU B , KIWAN C , et al . The role of Wnt/β-catenin pathway mediators in aortic valve stenosis [J ] . Front Cell Dev Biol , 2020 , 8 : 862 .
WANG B , LI F , ZHANG C , et al . High-mobility group box-1 protein induces osteogenic phenotype changes in aortic valve interstitial cells [J ] . J Thorac Cardiovasc Surg , 2016 , 151 ( 1 ): 255 - 262 .
CUI J , ZHANG M , ZHANG YQ , et al . JNK pathway: diseases and therapeutic potential [J ] . Acta Pharmacol Sin , 2007 , 28 ( 5 ): 601 - 608 .
杨阳 , 姚智超 , 霍丽蓉 . 程序性细胞死亡相关途径调控血管钙化 [J ] . 中国动脉硬化杂志 , 2023 , 31 ( 12 ): 1098 - 1104 .
0
浏览量
167
下载量
1
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621